We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPI icon
1576
Group 1 Automotive
GPI
$4.17B
$2.53M 0.01%
14,000
+4,343
+45% +$764K
BLKB icon
1577
Blackbaud
BLKB
$1.65B
$2.53M 0.01%
42,900
-77,911
-64% -$4.36M
LCAAW
1578
CALL
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$2.52M 0.01%
249,996
CRZNW
1579
CALL
DELISTED
Corazon Capital V838 Monoceros Corp Warrant
CRZNW
$2.52M 0.01%
249,996
BETRW icon
1580
CALL
Better Home & Finance Warrant
BETRW
$2.28M
$2.52M 0.01%
250,000
RDY icon
1581
Dr. Reddy's Laboratories
RDY
$9.77B
$2.52M 0.01%
+243,675
New +$2.63M
GLW icon
1582
Corning
GLW
$108B
$2.51M 0.01%
78,620
-425,218
-84% -$13.8M
BSLKW
1583
CALL
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$2.5M 0.01%
249,997
COP icon
1584
ConocoPhillips
COP
$139B
$2.5M 0.01%
+21,196
New +$2.58M
BZH icon
1585
Beazer Homes USA
BZH
$913M
$2.5M 0.01%
195,731
+129,540
+196% +$1.57M
MNSO icon
1586
MINISO
MNSO
$3.73B
$2.49M 0.01%
232,078
-793,705
-77% -$6.65M
PVLA
1587
Palvella Therapeutics
PVLA
$2.05B
$2.49M 0.01%
29,900
-615
-2% -$49.4K
NGG icon
1588
National Grid
NGG
$81.3B
$2.48M 0.01%
43,637
+7,446
+21% +$398K
M icon
1589
Macy's
M
$6.62B
$2.48M 0.01%
120,024
-88,345
-42% -$1.81M
UEC icon
1590
Uranium Energy
UEC
$4.67B
$2.48M 0.01%
638,275
-178,329
-22% -$677K
JAKK icon
1591
Jakks Pacific
JAKK
$305M
$2.48M 0.01%
141,546
-26,913
-16% -$491K
PDOT.WS
1592
CALL
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$2.47M 0.01%
242,956
SMRT icon
1593
SmartRent
SMRT
$193M
$2.47M 0.01%
1,017,129
-2,938,662
-74% -$7.27M
NCACW
1594
CALL
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
$2.47M 0.01%
240,385
OTECW
1595
CALL
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
$2.46M 0.01%
233,624
ACAQ.WS
1596
CALL
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$2.46M 0.01%
231,619
GM icon
1597
PUT
General Motors
GM
$81.7B
$2.45M 0.01%
72,800
+59,500
+447% +$2.2M
NSTB.WS
1598
CALL
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$2.44M 0.01%
243,993
HWKZ
1599
DELISTED
Hawks Acquisition Corp
HWKZ
$2.44M 0.01%
244,042
KD icon
1600
Kyndryl
KD
$2.94B
$2.43M 0.01%
218,482
-2,008,956
-90% -$20.2M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.